Cha J, Farrel JA, Ahmed SF, Frey A, Hsiao-Ashe KK, Young AB, Penney JB, Locascio JJ, Hyman BT and Irizarry MC (2001). Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein. Neurobiol Dis; 8: 90-102.
Vonsattel JP, Hedley-Whyte ET and DiFiglia M (2001). Huntington disease with emphasis on late onset and aging. in memory of dr. edward peirson richardson, jr. Pathology of the Aging Human Nervous System (2nd ed.). S Duckett and JC de la Torre (Eds.). Oxford, UK, Oxford University Press: 369-391.
Bacskai BJ, Kajdasz ST, Christie RH, Carter C, Games D, Seubert P, Schenk D and Hyman BT (2001). Imaging of amyloid-ß deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nature Medicine; 7: 1-4.
Walsh DM, Hartley DM, Condron MM, Selkoe DJ and Teplow DB (2001). In vitro studies of amyloid protein fibril assembly and toxicity provide clues to the etiology of flemish variant (ala692® gly) alzheimer’s disease. J Biol Chem; 355: 869-877.
Solomon PR (2001). Model systems and memory: applications and extensions to clinical neuroscience. Model Systems in Neurobiology of Associative Learning: A Festschrift in honor of Richard E. Thompson. JE Steinmetz, M Cluck and P Solomon (Eds.). Mahwah, NJ, Lawrence E. Erlbaum: 111-148.
Adamec E, Yang F, Cole, GM and Nixon, RA (2001). Multiple-label immunocytochemistry for the evaluation of nature of cell death in experimental models of neurodegeneration. Brain Research Protocols; 7: 193-202.